Sabatini Brent sold VIR
February 24, 2026 · Form 4 insider transaction
Sabatini Brent sold 1,430 shares of Vir Biotechnology, Inc. at $9.53 per share, a transaction worth $13.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,430
Price
$9.53
Total value
$13.6K
InsiderSabatini Brent
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 24, 2026
Filing dateFebruary 26, 2026
Shares owned after69,613
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.